Wolverine Trading
LJPC

Wolverine Trading’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Wolverine Trading’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,200
Closed -$63K – 7446
2021
Q2 		$63K Buy
+14,200
New +$60.8K ﹤0.01% 5557
2019
Q3 		– Sell
-15,000
Closed -$139K – 5446
2019
Q2 		$139K Buy
+15,000
New +$113K ﹤0.01% 3894
2018
Q3 		– Sell
-15,900
Closed -$474K – 6574
2018
Q2 		$474K Hold
15,900
– – ﹤0.01% 3160
2018
Q1 		$474K Sell
15,900
-10,000
-39% -$322K ﹤0.01% 3160
2017
Q4 		$833K Buy
25,900
+9,900
+62% +$324K ﹤0.01% 2421
2017
Q3 		$556K Buy
+16,000
New +$515K ﹤0.01% 2500

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Wolverine Trading's LJPC Position: Q2 2020 in Review

Wolverine Trading sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 11,442 shares — an estimated $48K sold.

Wolverine Trading first reported a position in LJPC in Q4 2017 and held it in 5 quarters. The position peaked at $348K in Q4 2017. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

  • Wolverine Trading reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
  • Wolverine Trading sold 11,442 La Jolla Pharmaceutical Company shares in Q2 2020, an estimated $48K.
  • Wolverine Trading first reported a position in La Jolla Pharmaceutical Company in Q4 2017 and held it in 5 quarters.
  • Wolverine Trading's La Jolla Pharmaceutical Company position peaked at $348K in Q4 2017.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.